Comparative Performance of a Routine Immunoturbidimetric Glycated Hemoglobin Assay and High-Pressure Liquid Chromatography Method
Introduction Hemoglobin A1c (HbA1c) testing is used for the diagnosis of diabetes and glycemic monitoring. This study compares an immunoturbidimetric assay with high-performance liquid chromatography (HPLC) to assess analytical agreement and determine the clinical suitability of the immunoturbidimetric method for diagnosis versus long-term monitoring in a local setting, in alignment with international standards. Methods A comparative cross-sectional study was conducted in a routine laboratory in Madagascar. Samples were tested on the same day using the Bio-Rad D-10 (Bio-Rad Laboratories, Hercules, CA) and Mindray BS-300 (Mindray, Shenzhen, China) automated analyzers. Analytical accuracy was assessed using control materials. The two methods were compared by evaluating the correlation using Pearson's coefficient (r) and linear regression, and the concordance using the Bland-Altman plot and Passing-Bablok regression. The HbA1c results were divided into a total group and subgroups (HbA1c < 6.5%, 6.5-8%, and > 8%). Results Intra-assay, inter-assay, and overall precision are satisfactory (coefficients of variation (CV) <3%) for routine use of both techniques. A good overall correlation between the immunoturbidimetric technique and HPLC was found with r = 0.88. The Bland-Altman plot shows a proportional increase in mean bias with HbA1c values and the regression equation [Formula: see text]. Conclusion This study showed good correlation between the two techniques, but a systematic underestimation of HbA1c levels by the immunoturbidimetry assay was observed, especially for high values.
Authors
- Soja M Rakotomalala
- Miora K Ranaivosoa
- Faralahy H Rakotonjafiniarivo
- Tokinomenjanahary Antsonantenaina
Institutions
- University of Antananarivo (MG)
Publication Details
- Journal
- Cureus
- Published
- 2026-01-07
- DOI
- https://doi.org/10.7759/cureus.101019
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00